Circumvent Pharmaceuticals Company
Circumvent Pharmaceuticals is seeking to address the significant unmet need of neurodegenerative disease patients. Circumvent is targeting heritable forms of neurodegeneration to enable drug discovery and development in both rare and common forms of neurodegenerative disease. Circumvent is funded by NIH/NINDS, YC Bio, Heritage Provider Network, and the Longevity Fund
Technology:
Geroscience
Industry:
Biotechnology, Health Care, Pharmaceutical
Headquarters:
Portland, Oregon, United States
Founded Date:
2017-01-01
Employees Number:
1-10
Funding Status:
Seed
Register and Claim Ownership